| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5555628 | Journal of the American Pharmacists Association | 2017 | 6 Pages |
Abstract
It is concerning that 20%-30% of pharmacists recommended a medication to “reverse” the course of AD, about one-half of pharmacists could not mention a single adverse effect of donepezil, and more than one-fourth of pharmacists made an inappropriate self-care sleep aid recommendation for a person with AD who was using rivastigmine patch. Although overall results regarding pharmacists' knowledge were poor, performance was significantly poorer in low-income areas. As our AD population increases, we need to strengthen pharmacists' knowledge on and competencies important for pharmacy-related AD care.
Related Topics
Health Sciences
Medicine and Dentistry
Public Health and Health Policy
Authors
Marketa Marvanova, Paul Jacob Henkel,